1. Anita R, Paramasivam A, Priyadharsini JV, Chitra S (2020) The m6A readers YTHDF1 and YTHDF3 aberrations associated with metastasis and predict poor prognosis in breast cancer patients. Am J Cancer Res 10(8):2546–2554
2. Bausch D, Mino-Kenudson M, Castillo FC, Warshaw AL, Kelly KA, Thayer SP (2009) Plectin-1 is a biomarker of malignant pancreatic intraductal papillary mucinous neoplasms. J Gastrointest Surg 13(11):1948–1954. https://doi.org/10.1007/s11605-009-1001-9
3. Bausch D, Thomas S, Mino-Kenudson M, Fernández-del CC, Bauer TW, Williams M, Warshaw AL, Thayer SP, Kelly KA (2011) Plectin-1 as a novel biomarker for pancreatic cancer. Clin Cancer Res 17(2):302–309. https://doi.org/10.1158/1078-0432
4. Buckley MF, Sweeney KJ, Hamilton JA, Sini RL, Manning DL, Nicholson RI, deFazio A, Watts CK, Musgrove EA, Sutherland RL (1993) Expression and amplification of cyclin genes in human breast cancer. Oncogene 8:2127–2133
5. Buckup M, Rice MA, HsuEC G-M, Liu S, Aslan M, Bermudez A, Huang J, Pitteri SJ, Stoyanova T (2021) Plectin is a regulator of prostate cancer growth and metastasis. Oncogene 40(3):663–676. https://doi.org/10.1038/s41388-020-01557-9